Capros, fromNatreon, a standardized extract ofPhyllanthus emblica, which covers a composition and method to treat or prevent endothelial dysfunction. It recently received a patent from the Canadian patent office. Designed to improve endothelial function and cardiovascular health, the claim reads, “use of a composition to treat or prevent endothelial dysfunction in an individual, the composition comprises an extract of pulpedPhyllanthus emblicaand a pharmaceutically acceptable carrier, wherein endothelial function is improved.”

Published in WholeFoods Magazine December 2017